Actively Recruiting
Study of Biliary Atresia in Children and Young Adults with Their Native Liver
Led by Arbor Research Collaborative for Health · Updated on 2026-06-04
1265
Participants Needed
16
Research Sites
N/A
Total Duration
On this page
Sponsors
A
Arbor Research Collaborative for Health
Lead Sponsor
N
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are studying biliary atresia, a liver condition in infants and children, to better understand what causes it and how it progresses over time. This observational study aims to identify the genes involved in biliary atresia and to describe the natural history of older children who still have their native liver. The study is conducted by the Childhood Liver Disease Research Network funded by the National Institute of Diabetes & Digestive and Kidney Diseases. The study involves collecting clinical information, genetic material, and body fluid samples from participants once, usually at the start of the study. Participants include children and young adults aged over 6 months up to 20 years who have a confirmed diagnosis of biliary atresia and still have their native liver. Researchers will follow these participants yearly to gather observational data about disease progression and quality of life. Participants will be asked to attend yearly follow-up visits where observational information will be collected, including health status and growth measurements. The primary measurement is to identify genetic factors linked to biliary atresia, while secondary outcomes include understanding disease progression and quality of life over time. The study tracks important health events, growth, and nutritional status to help predict outcomes. Participation may last several years, with annual visits to monitor the condition and collect data.
CONDITIONS
Brief Title
Biliary Atresia Study in Infants and Children
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants must have a confirmed diagnosis of biliary atresia based on medical records including biopsy, radiology, and surgery reports.
- Participants must be older than 6 months and up to 20 years of age.
- Participants must still have their native liver (no liver transplant).
- Parent, guardian, or participant (if 18 or older) must be willing to provide informed consent and assent when appropriate.
You will not qualify if you...
- Currently participating in the ChiLDReN study PROBE.
- Unable to confirm the original diagnosis of biliary atresia.
- Unable or unwilling to participate in all scheduled study visits.
- History of liver transplantation.
Research Team
M
Melissa Sexton, BBA, CCRP
M
Melissa Sexton, BBA
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here